Fund profile
Tickers
MEDX
Fund manager
Total assets
$18.06 mm
Liabilities
$1.40 mm
Net assets
$16.67 mm
Number of holdings
37.00
37 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
US BANK MMDA - USBGFS 7 | 2.09 mm | 2.09 mm shares | 12.53 | Short-term investment vehicle | Long | USA |
LLY Lilly(Eli) & Co | 1.96 mm | 3.36 k shares | 11.75 | Common equity | Long | USA |
ABBV Abbvie Inc | 1.19 mm | 7.68 k shares | 7.14 | Common equity | Long | USA |
NVS Novartis AG | 969.01 k | 9.60 k shares | 5.81 | Common equity | Long | Switzerland |
AMGN AMGEN Inc. | 967.46 k | 3.36 k shares | 5.80 | Common equity | Long | USA |
BMY Bristol-Myers Squibb Co. | 911.01 k | 17.76 k shares | 5.47 | Common equity | Long | USA |
JNJ Johnson & Johnson | 902.67 k | 5.76 k shares | 5.42 | Common equity | Long | USA |
AZN Astrazeneca plc | 840.26 k | 12.48 k shares | 5.04 | Common equity | Long | UK |
BIIB Biogen Inc | 807.10 k | 3.12 k shares | 4.84 | Common equity | Long | USA |
PFE Pfizer Inc. | 746.01 k | 25.91 k shares | 4.48 | Common equity | Long | USA |
MRK Merck & Co Inc | 732.40 k | 6.72 k shares | 4.39 | Common equity | Long | USA |
CRSP CRISPR Therapeutics AG | 660.87 k | 10.56 k shares | 3.97 | Common equity | Long | Switzerland |
ALKS Alkermes plc | 638.94 k | 23.03 k shares | 3.83 | Common equity | Long | Ireland |
REGN Regeneron Pharmaceuticals, Inc. | 632.37 k | 720.00 shares | 3.79 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals Inc | 631.16 k | 12.48 k shares | 3.79 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 551.26 k | 2.88 k shares | 3.31 | Common equity | Long | USA |
NTLA Intellia Therapeutics Inc | 438.93 k | 14.40 k shares | 2.63 | Common equity | Long | USA |
GSK GSK Plc | 417.48 k | 11.27 k shares | 2.50 | Common equity | Long | UK |
EDIT Editas Medicine Inc | 320.82 k | 31.67 k shares | 1.92 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc | 261.23 k | 9.60 k shares | 1.57 | Common equity | Long | USA |
BCYC Bicycle Therapeutics Plc | 260.28 k | 14.40 k shares | 1.56 | Common equity | Long | UK |
LTRN Lantern Pharma Inc | 123.23 k | 28.79 k shares | 0.74 | Common equity | Long | USA |
REPL Replimune Group Inc | 121.36 k | 14.40 k shares | 0.73 | Common equity | Long | USA |
HLN Haleon plc | 115.89 k | 14.08 k shares | 0.70 | Common equity | Long | UK |
CFRXQ CONTRAFECT Corp | 112.98 k | 11.52 k shares | 0.68 | Common equity | Long | USA |
VNDA Vanda Pharmaceuticals Inc | 109.35 k | 25.91 k shares | 0.66 | Common equity | Long | USA |
GALT Galectin Therapeutics Inc | 89.21 k | 53.74 k shares | 0.54 | Common equity | Long | USA |
GEHC GE HealthCare Technologies Inc | 74.23 k | 960.00 shares | 0.45 | Common equity | Long | USA |
TSVT 2seventy bio Inc | 73.76 k | 17.27 k shares | 0.44 | Common equity | Long | USA |
ALLO Allogene Therapeutics Inc | 61.61 k | 19.19 k shares | 0.37 | Common equity | Long | USA |
SDZNY Sandoz Group Ag | 61.46 k | 1.92 k shares | 0.37 | Common equity | Long | Switzerland |
BLUE Bluebird bio Inc | 50.33 k | 36.47 k shares | 0.30 | Common equity | Long | USA |
VTRS Viatris Inc | 38.68 k | 3.57 k shares | 0.23 | Common equity | Long | USA |
RAIN Rain Oncology Inc | 28.79 k | 23.99 k shares | 0.17 | Common equity | Long | USA |
SLRX Salarius Pharmaceuticals Inc | 19.90 k | 31.09 k shares | 0.12 | Common equity | Long | USA |
MURA Mural Oncology plc | 13.64 k | 2.30 k shares | 0.08 | Common equity | Long | Ireland |
IMNPQ Immune Pharmaceuticals Inc | .000000000000 | 1.00 shares | 0.00 | Common equity | Long | USA |